BioSpace News Archive

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (“Actinium”) today highlighted that four abstracts detailing the Company’s clinical trials for Iomab-B and Actimab-A will be presented at the 62nd American Society of Hematology (ASH) Annual Meeting, which is being held virtually December 5-8, 2020.

Lantheus Holdings, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and products, announced its entry into a stock purchase agreement to sell its Puerto Rico radiopharmacy and positron emission tomography manufacturing facility to PharmaLogic Holdings Corp.

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced three poster presentations at the 31 st International Symposium on ALS/MND taking place online from December 9 – December 11, 2020. Title: A Phase 3, Multi-Center, Double-Blind, Randomized, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Reldesemtiv in Patients with Amyotrophic Lateral Sclerosis (ALS): COURAGE-ALS Trial Design Session: Live

EVERSANA will leverage ArisGlobal’s end-to-end LifeSphere Safety platform to strengthen next-generation commercialization services

Inspira Technologies Ltd., an innovative medical technology company, announced today that it filed a patent application with the United States Patent and Trademark Office (USPTO) for its new blood oxygenation system, the AXT, which eliminates the need for invasive mechanical ventilation.

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI) , a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that David McNally, President, CEO and Chairman of Titan Medical, will present an overview of the Company and its Enos ™ single access surgical system to a live virtual audience at the Benzinga Global Small Cap Con

Tissue Analytics, a Net Health company that provides software solutions for the wound care industry, announced today that the company has launched a first-of-its-kind program to allow medical device manufacturers and software companies to leverage Tissue Analytics’ market-leading application programming interfaces (APIs).

BioAge Labs, Inc., a biotechnology company developing medicines to treat aging and aging-related diseases, today announced that it has raised $90 million in an oversubscribed Series C financing

Jazz Pharmaceuticals plc, along with its partner, PharmaMar, announce results from the ATLANTIS Phase 3 multicenter, randomized, controlled study evaluating Zepzelca™ in combination with doxorubicin versus physician’s choice of topotecan or cyclophosphamide/doxorubicin/vincristine for adult patients with small cell lung cancer whose disease progressed following one prior platinum-containing line.

LivaNova PLC, a market-leading medical technology and innovation company, and Gyrus Capital, an investment firm dedicated to investments in the healthcare and sustainability sectors, announced they have entered into an agreement whereby entities funded and controlled by Gyrus will acquire the LivaNova heart valve business.